Kyle Diamantas represents food, dietary supplement, drug, cosmetic, and consumer products clients and supply chain participants on issues involving labeling, advertising, and regulatory and quality compliance and in transactions involving products and companies subject to U.S. Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) regulations.
Kyle handles complex commercial litigation with respect to FDA and USDA regulated products, general consumer products, and related advertising and marketing issues, among other general civil matters. He has experience in multidistrict, class action, and mass action litigation, including multidistrict products liability litigation related to a blockbuster antipsychotic drug; class action litigation related to cannabidiol (CBD), talcum powder, poultry, and various other food, supplement, and consumer products; false advertising and claim substantiation litigation; multidistrict antitrust litigation alleging anticompetitive behavior on the part of automobile insurers; and litigation stemming from the BP oil spill in the Gulf of Mexico.
- University of Florida (J.D. magna cum laude 2013); University of Central Florida (B.A. in Political Science 2010)
- Florida and District of Columbia
Recognized as a "Rising Star" in the area of food and drugs by Florida Super Lawyers (2018-2021)
Recognized by The Best Lawyers in America as "Ones to Watch" for litigation (2021)